BLSH heads into July with its lending market fully exhausted, short interest climbing sharply, and a stock down a third in a single month — a combination that frames the digital asset exchange as one of the more charged short setups in the financial data sector right now.
The borrow market tells the most striking story this week. Availability has collapsed to just 2% — meaning for every fifty shares already lent out, only one remains available to borrow. That reading arrived after a dramatic move: availability was above 26% as recently as June 25, and above 34% in late May. The lending pool has essentially been emptied in less than a week. Cost to borrow, at 1.39%, has actually eased from last week's peak near 1.78%, but that modest CTB figure reflects the fact that most of the repositioning has already happened — lenders are not yet charging a premium because demand has been satisfied, not because the borrow pressure has faded. Short interest itself reinforces the picture: it has risen 18% over the past week to 8.2% of the free float, and 32% over the past month, crossing the 12 million shares level. ORTEX's short score has climbed to 79.4, its highest reading in the tracked history, ranking in the first percentile of the universe on both short score and utilization.
Options positioning cuts against the bearish grain. The put/call ratio has dropped to 0.59, nearly two standard deviations its 20-day average of 0.70 — placing it near its most call-heavy reading in the past year. That divergence is worth naming directly: while the lending market is signalling maximum bearish commitment, the options market shows investors more interested in upside exposure than downside protection. The PCR has been drifting lower all week, from 0.72 on Monday to 0.59 by Tuesday's close, even as short interest was rising each day. Two markets, two different reads on where BLSH goes next.
The analyst community is sitting on the sidelines with a hold consensus, but the recent direction of travel is one-way. JP Morgan's Kenneth Worthington, acting within the past two weeks, cut his price target from $43 to $26 — a 40% reduction — while keeping a Neutral rating. That single move drags the mean target down materially. The gap between the consensus target of $46 and the current price of $23.43 looks wide on paper, but with the stock having shed 33% in a month, several of those targets — Citi still carries $65 — reflect pre-drawdown views and should be treated with caution. The bear case centres on slowing institutional crypto adoption, execution risk from the Equiniti acquisition, and a regulatory environment that can shift quickly. Bulls point to Bullish's infrastructure positioning in stablecoins and blockchain settlement as a longer-cycle growth story. Valuation multiples have compressed hard: the PE multiple has fallen more than 15 points over 30 days to 32.8x, and price-to-book is down 0.43 over the same period to 1.35x. Forward EPS growth expectations rank in the 97th percentile of the universe, but near-term EPS momentum scores in the bottom decile — a tension between structural promise and immediate delivery.
Earnings are due August 13. The May print was severe — the stock fell nearly 15% on the day and lost another point over the following five days. With short interest at cycle highs, availability near zero, and a CEO who sold approximately $6.4 million in shares at prices well above current levels in April and May, the August print is the next hard date that will test whether the current short positioning is vindicated or forced to unwind.
See the live data behind this article on ORTEX.
Open BLSH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
